Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 1.1 Form of Underwriting Agreement
- 3.1 Certificate of Incorporation
- 3.2 First Amended and Restated Certificate of Incorporation
- 3.3 Bylaws
- 4.1 Specimen Unit Certificate
- 4.2 Specimen Common Stock Certificate
- 4.3 Specimen Warrant Certificate
- 4.4 Form of Warrant Agreement Between Continental Stock Transfer & Trust Company, LLC and the Registrant
- 5.1 Opinion of Robinson & Cole LLP
- 10.1 Promissory Note, Dated February 18, 2022, Issued to Biotech Group Acquisition Sponsor LLC
- 10.2 Form of Letter Agreement Among the Registrant and Initial Shareholders
- 10.3 Form of Investment Management Trust Agreement Between Continental Stock Transfer & Trust Company, LLC and the Registrant
- 10.4 Form of Registration Rights Agreement Among the Registrant and Certain Security Holders
- 10.5 Securities Subscription Agreement, Between the Registrant and the Sponsor Dated February 18, 2022
- 10.6 Securities Subscription Agreement, Between the Registrant and the CEO Dated February 18, 2022
- 10.7 Securities Subscription Agreement, Between the Registrant and the CFO Dated February 18, 2022
- 10.8 Form of Private Placement Units Purchase Agreement Between the Registrant and the Sponsor
- 10.9 Form of Indemnity Agreement
- 10.10 Form of Securities Transfer Agreement
- 14.1 Form of Code of Ethics
- 23.1 Consent of Malonebailey, LLP
- 99.1 Form of Audit Committee Charter
- 99.2 Form of Compensation Committee Charter
- 99.3 Consent of Jingmin (Helen) Rogers
- 99.4 Consent of John Brugmann
- 99.5 Consent of Yi Wung
- 99.6 Consent of Manu Ohri
- EX-FILING FEES Filing Fee Exhibit
Associated filings
BGAC similar filings
Filing view
External links
Exhibit 99.5
CONSENT OF YI WUNG
Biotech Group Acquisition Corporation intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto the “Registration Statement”), registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named in the Registration Statement as a Director Nominee.
April 15, 2022 | /s/ Yi Wung |
Yi Wung |